tiletamine hydrochloride has been researched along with Cancer of Mouth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Chen, X; Du, YD; Han, CM; Li, SW; Zhang, C; Zhang, XY; Zhou, QQ; Zhou, XY | 1 |
| Kondo, S; Mukudai, Y; Nagumo, T; Shintani, S; Tsukamoto, H; Umezawa, K; Yasuda, A | 1 |
2 other study(ies) available for tiletamine hydrochloride and Cancer of Mouth
| Article | Year |
|---|---|
The C8 side chain is one of the key functional group of Garcinol for its anti-cancer effects.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclohexanones; Fruit; Garcinia; Humans; Methylation; Mouth Neoplasms; Terpenes | 2017 |
Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cyclohexanones; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inhibitor of Apoptosis Proteins; Mice; Mouth Neoplasms; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2011 |